Abstract

IntroductionIn mechanical thrombectomy (MT) candidates, tenecteplase (TNK) has shown improved reperfusion and outcomes. Therefore, in October of 2020, we transitioned to TNK as the primary thrombolytic for patients presenting with...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call